Malvinder Mohan Singh
Executive Chairman, Fortis Healthcare Limited
Malvinder is a dynamic, young business leader who has made a mark on the global landscape by simultaneously pursuing the twin objectives of business for profit and for public good, in a way that positively impacts lives.
With the intent of providing broad based world class services through transformative business and delivery models, Malvinder is shaping the contours of the healthcare and financial services industries and driving their evolution.
In Healthcare, Malvinder incubated and established Fortis Healthcare Limited, in the late 1990's. Since then, he has been instrumental in transforming it into a leading healthcare delivery company in India and more recently in Asia, as the largest emerging healthcare organisation.
With a vision of making quality healthcare services accessible to all, he continues to assiduously pursue this objective, to make it a reality, using innovative business models.
In the Financial Services and Insurance sectors, Malvinder has business interests through Religare Enterprises. As Chairman of the company till 2010, he evolved Religare's strategy of creating an integrated financial services organization in India and an emerging global asset management platform.
Previously, Malvinder was Chairman, MD and CEO of Ranbaxy Laboratories. He led the expansion of Ranbaxy through a series of strategic partnerships and acquisitions resulting in Ranbaxy becoming a top 10 generic pharmaceutical company, globally. He spearheaded the coming together of Ranbaxy and Daiichi Sankyo, to create the world's fifteenth largest pharmaceutical company – a move seen as a game-changer by industry experts.
Malvinder strongly believes in the ability of people to do extraordinary things, in challenging environments. In a precedence setting move, he entrusted the management of Religare to a professional management team by stepping down as Chairman of the company in 2010. He continues to oversee his family's majority interest in Religare, as shareholder.
Malvinder has always supported strategic business decisions in the best interest of the companies he has led and continues to lead. The sale of his personal stake in Ranbaxy to Daiichi Sankyo, to secure longevity and a place for Ranbaxy as a top ranking Global Pharmaceutical Company and his decision to exit investments in Parkway Healthcare, emphatically demonstrated his ability to steer his companies, always keeping the best interests of its stakeholders, in mind.
Malvinder has a strong personal belief in the social responsibility of individuals and corporates. With a focus on affordability and accessibility to life saving medicines in emerging and under developed countries; he channelled resources towards innovation, to reduce the cost of ARV medication and for the development of a new low cost synthetic anti-malarial drug. He keenly supports initiatives to provide curative and preventive healthcare to the under privileged in India's villages and urban slums through various foundations and trusts.
Malvinder is a member of the Board of Visitors at the Fuqua School of Business (Duke University, USA) and the Board of the Indian Council for Research on International Economic Relations (ICRIER). He was a member of the first batch of the Young Global Leaders initiative of the World Economic Forum. A graduate in Economics, he earned his MBA from the Fuqua School of Business, Duke University, USA.
Shivinder Mohan Singh
Executive Vice Chairman, Fortis Healthcare Limited
Shivinder Mohan Singh is an entrepreneur who aspires to change the way Healthcare is delivered in the world. He is the Executive Vice Chairman of Fortis Healthcare Limited, a leading, integrated healthcare delivery provider in the Pan Asia-Pacific region. Fortis' healthcare verticals span primary healthcare, speciality day care, diagnostics and hospitals, with an asset base in 10 countries, many of which represent the fastest-growing healthcare delivery markets in the world. Fortis is driven by the vision of becoming a global leader in the integrated healthcare delivery space and the larger purpose of saving and enriching lives through clinical excellence.
Shivinder is also one of the principal promoters of Religare Enterprises Limited, Super Religare Laboratories Limited and Religare Technologies Limited. He was one of the key promoters of global pharma major Ranbaxy Laboratories and a director on its board; playing a strategic role in its sale and in taking the company to the next level, while creating significant long-term value for all stakeholders.
Shivinder has done his MBA with specialisation in health sector management from the Duke University Business School, USA. His significant contribution to Indian Healthcare is widely acknowledged. His strategy for Fortis, and its execution, has been recognised by the Harvard Business School as a case study. For over a decade, Shivinder has led from the front in shaping the private healthcare space in India. He is an alumnus of Doon School and an Honours Graduate in Mathematics from St. Stephens College, Delhi. He has lead various healthcare bodies and state level initiatives for the industry. He is also the Chairman of the Membership Committee of FICCI (Federation of Indian Chambers of Commerce and Industry).
While healthcare is a passion for Shivinder, his dream is to contribute in building a vibrant India. He is involved in a number of initiatives focused on social change - a better future for the girl child, HIV education, quality healthcare in Rural India and more. Shivinder is on the board of visitors of Fuqua School of Business, Duke University, USA and the board of trustees of Aspen India. He is also on the national board of advisors for AIESEC, a global, non-political and independent, not-for-profit organization run by students and graduates from institutions of higher education.
Shivinder lives with his wife Aditi and their four sons, in New Delhi. He likes sports such as football and tennis and enjoys watching films! .
President, Fortis Healthcare Limited
Daljit Singh is the President, Fortis Healthcare Limited. He has led the Company's strategy and organizational development functions and has held the office of CEO. He has over 39 yrs of rich management experience.
Mr Singh has been a pivotal member of the top team of Fortis that formulated and implemented Fortis' growth strategy to position it as India's leading Healthcare delivery organization in a short span of 10 yrs.
Prior to joining Fortis, Mr Singh was on the Board of Directors of ICI India, a subsidiary of the British Multinational, as the Executive Director in charge of Human Resources, Manufacturing, External Relations and Communications. Amongst key responsibilities held, he was the Chief Executive for Pharmaceuticals, Specialties and Catalyst businesses. He was member of the ICI Global Manufacturing Group, SSHE Excellence Group and the Global HR Forum. His key experience and achievements have been in the areas of developing progressive HR strategies and ensuring their implementation, organizational restructuring, building a high performance culture and leading teams to deliver business value. He has successfully planned and executed significant change programs.
Mr Singh is an acknowledged expert and thought leader in the domain of Healthcare Delivery. He is on the Steering Boards constituted by the World Economic Forum to guide two major Global projects: "Scenarios for Sustainable Health Systems" and "The Healthy Living Charter". He is also on the Forum's Advisory Board on "The Economic Burden of Non Communicable Diseases in India".
A certified Life and Executive Coach, he works with Senior Management to enhance personal performance and fulfillment. He also leads and facilitates workshops on Strategy, Business Planning & Leadership.
A graduate from the Indian Institute of Technology, Delhi, and Mr. Singh was a Commonwealth Scholar to the Senior Management Programme at the Manchester Business School in 1995. With an outstanding track record in the field of athletics, his current interests include athletics, high altitude trekking, adventure sports, music and reading.
Balinder Singh Dhillon
President, Fortis Healthcare Limited
Balinder Singh Dhillon is a President of Fortis Healthcare Limited. He has been on corporate boards, including those of Ranbaxy Laboratories Ltd, an India listed multi-billion dollar multinational pharmaceutical company, and Parkway Holdings Ltd, a Singapore listed healthcare services company. He has also worked as counsel in practice and with corporate houses such as Hindustan Unilever Limited and INTRIA Items Inc.,(a wholly owned subsidiary of CIBC Bank, Canada). He has more than two decades of experience in corporate law, governance, risk management, and strategic planning and implementation.
A graduate of the Panjab University, Balinder is also a member of the Institute of Company Secretaries of India and the Bar Council of India. He holds a Master of Laws degree from McGill University, Canada. As a member of the Law Society of Upper Canada, he completed his accreditation under a Certificate of Qualification equivalent to a Graduate of Law through the Law Faculty, University of Toronto, Canada
Gagandeep Singh Bedi
Group Chief Financial Officer, Fortis Healthcare Limited, India
Mr. Gagandeep Singh Bedi holds a Bachelor's degree in Commerce from Delhi University and is a Chartered Accountant from the Institute of Chartered Accountants of India. He has over 18 years of wide experience in the areas of Finance, Total Quality Management, leading a business and a global transformation program. Mr. Bedi joined Fortis Healthcare in 2011 from Philips Healthcare, Netherlands. At Fortis, he set up the Supply Chain and Shared Services function and has delivered exceptional results.
Chief Financial Officer, Fortis Healthcare International
Srivatsan graduated in Commerce with professional qualifications in Finance, from the Institute of Cost and Works Accountants of India, and Legal, from the Institute of Company Secretaries of India. His overall experience of over 20 years spans pharmaceuticals, healthcare and shipping. Srivatsan has been with Fortis Healthcare since 2011. Prior to joining Fortis Healthcare, he has been with Cipla Limited, Sanofi Aventis Limited, Panacea Biotec Limited, Wockhards Hospitals Limited and Mercator Lines (Singapore) Limited.
Srivatsan's dynamic professional career reflects pioneering experience & year-on-year success in achieving business growth objectives. He has cross functional exposure to Finance & Accounting, Technical, Commercial and Medico-Marketing operations. He is a sound business thinker who focuses on operations and pays attention to details while retaining the ability to look at the big picture: business beyond numbers. Srivatsan is a team player and has the ability to multi task and generate ideas and solutions.
Tan Poh Lan
Chief Executive Officer, Fortis Healthcare, Singapore
Tan Poh Lan is the Chief Executive Officer of Fortis Healthcare, Singapore. In this role, she is responsible for the healthcare business in Singapore, currently comprising Fortis Colorectal Hospital and RadLink-Asia Pte Ltd. She will be actively involved in growing the business in the country to increase the company's profile.
Poh Lan has more than 25 years of experience in the government and private healthcare settings in both Singapore and Vietnam with skills in operations, personnel management, performance/quality improvement and business development. A strong believer of teamwork, she works in collaboration with others toward mutual success of the team's objectives. She has a management style based on strong interpersonal and human relations skills and has the ability to build a motivated team with a strong customer focus.
Prior to joining Fortis, Poh Lan was the Chief Executive Officer of Vinmec International Hospital, Hanoi - a 500 bed hospital that was recently commissioned and started operations in January 2012. Before this, she has assumed senior leadership roles in Parkway Healthcare as the Chief Executive Officer of Gleneagles Hospital, Chief Executive Officer of East Shore Hospital and Assistant General Manager of Mount Elizabeth Hospital.
Poh Lan graduated from University of Queensland, Australia with a Bachelor of Occupational Therapy (Honours) under the Colombo Plan Scholarship. She has a Master of Business Administration from the National University of Singapore.
Dr. Simmardeep Singh Gill
Chief Operating Officer, Fortis Clinique Darne, Mauritius
Dr. Simmar Gill is a medical graduate and holds a Post-Graduation in Healthcare and Hospital Management. He has over twelve years of experience in the healthcare industry, ten of which have been at Fortis Healthcare. Before taking over as Chief of Fortis Clinique Darne, he was heading Fortis Hospitals, Bangalore, and was instrumental in turning it around from a sick unit into a renowned Kidney Institute of the region. Prior to his stint at Bangalore, Dr Gill successfully led Fortis Mohali to achieve a JCI and NABH accreditation, making it the first hospital in India to do so. In the course of his career, he has attended various prestigious programs linked to healthcare management and accreditations in the US and renowned management institutes in India. Simmar is passionate about running Fortis Hospitals with an aim to deliver top quality healthcare and world class services that Fortis is synonymous with.